Alabama biologics regulations.

Who may administer PRP, exosomes and stem cells in Alabama, and which agencies to check.

A physician at a desk reading regulatory documents

Who may administer biologics in Alabama?

In Alabama, certain licensed medical providers are qualified to administer stem cell therapies, such as physicians, osteopaths, and registered nurses under appropriate supervision.

Official sources

Alabama compliance guide.

FDA Compliance

The U.S. Food and Drug Administration (FDA) oversees human cells, tissues, and cellular and tissue-based products (HCT/P) through guidelines outlined in FDA’s HCT/P regulations. These guidelines cover:

  • Classification and criteria for products qualifying as HCT/Ps
  • Ensuring minimal manipulation of cells and homologous use
  • Registration and listing requirements with the FDAClinics must ensure that all biologic therapies meet FDA standards for safety and efficacy, aligning with these criteria to remain compliant.

Alabama State Regulations

Alabama has specific regulations governing the use of stem cell therapies. For state-specific compliance, clinics should refer to the Alabama Department of Public Health. Key points include:

  • Licensing and oversight requirements for clinics offering HCT/P services
  • Safety and sanitation standards specific to biologic handling
  • Must be a licensed physician (MD/DO)Following Alabama’s regulatory guidelines helps ensure accessible, safe practice for clinics interested in offering biologic therapies.

Provider Qualifications

In Alabama, certain licensed medical providers are qualified to administer stem cell therapies, such as physicians, osteopaths, and registered nurses under appropriate supervision. To learn more about licensure and credentialing in Alabama, refer to the Alabama Board of Medical Examiners.

Patient Informed Consent

Informed consent is critical for biologic therapies. In Alabama, informed consent must cover:

  • Potential benefits and risks associated with stem cell therapies
  • The experimental nature of some stem cell procedures
  • A statement that efficacy may vary depending on the individual. Consent should be documented and retained in patient records to protect both the clinic and patient.

Additional Compliance Requirements

Pre-Treatment and Post-Treatment Protocols

Adhering to clear pre- and post-treatment protocols helps ensure safe treatment outcomes. Providers are encouraged to develop protocols that align with Alabama and federal safety guidelines.

Standard Operating Procedures (SOPs)

Clinics should establish written SOPs for biologic handling, preparation, and patient follow-up. SOPs are key to maintaining compliance and providing consistent patient care.

Medical Liability Insurance

Clinics are advised to carry medical liability insurance that covers biologic treatments. This insurance helps manage risk and is essential for clinics offering experimental or emerging therapies.

Marketing and Advertising Compliance

When marketing biologic therapies, Alabama clinics must avoid false or misleading claims. Marketing materials should be compliant with both Alabama advertising standards and Federal Trade Commission (FTC) advertising guidelines.

This guide is a general summary to help clinics understand compliance requirements for biologics in Alabama. It is not legal advice. Regulations change; consult legal counsel and the agencies above before acting on it.

Alabama: common questions.

Who can administer stem cells, PRP and exosomes in Alabama?
In Alabama, certain licensed medical providers are qualified to administer stem cell therapies, such as physicians, osteopaths, and registered nurses under appropriate supervision. This is a general summary, not legal advice. Confirm with the state board.
Are stem cell and exosome therapies FDA-approved in Alabama?
FDA rules are federal, so they apply in Alabama as everywhere else. Exosome and stem cell therapies are not FDA-approved for therapeutic use, and PRP applications are considered off-label.
Do I need an IRB-approved study to offer biologics in Alabama?
Investigational treatment belongs inside a reviewed study with proper informed consent. IRB review is not FDA authorisation: culture-expanded and other more-than-minimally-manipulated cell products generally need an IND before use in people.
How do I start offering biologics in Alabama?
Start with the live webinar, then a discovery call and live training. After that we verify your Alabama licence, protocol, product sourcing, consent process and advertising before you are listed for patient inquiries.

Practising in Alabama? Start with the webinar.

Live on Zoom, Tuesdays at 12:00 PM ET. See how the model works before you commit to anything.